19-40804666-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000593445.5(EGLN2):​n.197A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.289 in 152,242 control chromosomes in the GnomAD database, including 7,948 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 7938 hom., cov: 32)
Exomes 𝑓: 0.30 ( 10 hom. )

Consequence

EGLN2
ENST00000593445.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.73

Publications

82 publications found
Variant links:
Genes affected
EGLN2 (HGNC:14660): (egl-9 family hypoxia inducible factor 2) The hypoxia inducible factor (HIF) is a transcriptional complex that is involved in oxygen homeostasis. At normal oxygen levels, the alpha subunit of HIF is targeted for degration by prolyl hydroxylation. This gene encodes an enzyme responsible for this post-translational modification. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the upstream RAB4B (RAB4B, member RAS oncogene family) gene. [provided by RefSeq, Feb 2011]
RAB4B-EGLN2 (HGNC:44465): (RAB4B-EGLN2 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring RAB4B (RAB4B, member RAS oncogene family) and EGLN2 (egl nine homolog 2) genes on chromosome 19. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.421 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EGLN2NM_080732.4 linkc.844-1889A>G intron_variant Intron 2 of 5 ENST00000303961.9 NP_542770.2
EGLN2NM_053046.4 linkc.844-1889A>G intron_variant Intron 2 of 5 NP_444274.1
RAB4B-EGLN2NR_037791.1 linkn.1892-1889A>G intron_variant Intron 8 of 11

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EGLN2ENST00000303961.9 linkc.844-1889A>G intron_variant Intron 2 of 5 1 NM_080732.4 ENSP00000307080.3
RAB4B-EGLN2ENST00000594136.2 linkn.*1093-1889A>G intron_variant Intron 8 of 11 2 ENSP00000469872.1
ENSG00000268797ENST00000601627.1 linkn.117+3251A>G intron_variant Intron 1 of 3 3 ENSP00000469533.1

Frequencies

GnomAD3 genomes
AF:
0.289
AC:
43958
AN:
151986
Hom.:
7931
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0751
Gnomad AMI
AF:
0.486
Gnomad AMR
AF:
0.430
Gnomad ASJ
AF:
0.297
Gnomad EAS
AF:
0.373
Gnomad SAS
AF:
0.378
Gnomad FIN
AF:
0.359
Gnomad MID
AF:
0.278
Gnomad NFE
AF:
0.361
Gnomad OTH
AF:
0.319
GnomAD4 exome
AF:
0.304
AC:
42
AN:
138
Hom.:
10
Cov.:
0
AF XY:
0.316
AC XY:
31
AN XY:
98
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
8
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
0.250
AC:
1
AN:
4
East Asian (EAS)
AF:
0.667
AC:
4
AN:
6
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2
European-Finnish (FIN)
AF:
0.389
AC:
7
AN:
18
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.341
AC:
30
AN:
88
Other (OTH)
AF:
0.00
AC:
0
AN:
12
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.541
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.289
AC:
43977
AN:
152104
Hom.:
7938
Cov.:
32
AF XY:
0.292
AC XY:
21698
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.0749
AC:
3109
AN:
41504
American (AMR)
AF:
0.430
AC:
6570
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.297
AC:
1030
AN:
3470
East Asian (EAS)
AF:
0.373
AC:
1926
AN:
5164
South Asian (SAS)
AF:
0.378
AC:
1825
AN:
4826
European-Finnish (FIN)
AF:
0.359
AC:
3794
AN:
10570
Middle Eastern (MID)
AF:
0.269
AC:
79
AN:
294
European-Non Finnish (NFE)
AF:
0.361
AC:
24516
AN:
67966
Other (OTH)
AF:
0.324
AC:
685
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1475
2950
4424
5899
7374
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
444
888
1332
1776
2220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.340
Hom.:
40256
Bravo
AF:
0.286
Asia WGS
AF:
0.394
AC:
1369
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.059
DANN
Benign
0.80
PhyloP100
-2.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3733829; hg19: chr19-41310571; COSMIC: COSV58280596; COSMIC: COSV58280596; API